Astellas details potential reason behind deaths in rare disease gene therapy trial
Four boys with a rare and often severe genetic muscle disease died in 2020 and 2021 after receiving a one-time gene therapy from Astellas Pharma …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
